silicone tgw ias2015 finalcfenet.ubc.ca/sites/default/files/uploads/ias2015/... · •...
TRANSCRIPT
• Transgender women con.nue to contend with high rates of HIV infec.on in many se8ngs.
• To enhance their feminine appearance, many transgender women undergo medically unsupervised body modifica.on procedures, such as self or peer-‐administered injec.on of industrial silicone (“airplane oil”).
• The use of non-‐sterile equipment and assisted injec.ng has been associated with increased risk for HIV acquisi.on and skin and soH .ssue infec.ons among people who inject drugs.
• The aim of this study was to assess the prevalence and correlates of industrial silicone injec.on among transwomen in Argen.na.
Prevalence and correlates of injec1on of industrial silicone among transgender women in Argen1na M. Eugenia Socias1, 2, 3, Thomas Kerr3,4, Brandon D.L. Marshall5, Inés Arístegui1, Claudia Frola1, 2, Héctor Pérez2, Pedro Cahn1, 2,, Omar Sued1, 2 1Fundación Huésped, BA, Argen.na 2Hospital Fernández, BA, Argen.na, 3BC Centre for Excellence in HIV/AIDS, Vancouver, Canada, 4University of Bri.sh Columbia, Department of Medicine, Vancouver, Canada, 5Brown University School of Public Health
BACKGROUND
METHODS • Data was drawn from a cross-‐sec.onal, na.on-‐wide study
involving transgender women in Argen.na conducted in 2013. • Bi-‐ and mul.-‐variable logis.c regression were used to
inves.gate correlates of industrial silicone injec.on
Contact: M. Eugenia Socias, [email protected]
CONCLUSIONS
• Our findings revealed that injec.on of industrial silicone is a common prac.ce among transgender women in Argen.na, especially among those engaged in high risk ac.vi.es (e.g., sex work) and those experiencing barriers to healthcare.
• Although no associa.on was found with HIV or HCV infec.on, this analysis was limited by self-‐report.
• Given the high prevalence of medically unsupervised and peer-‐assisted injec.ng in this sample, longitudinal studies are needed to inves.gate whether injec.on of industrial silicone is an important risk factor for HIV or HCV transmission among this popula.on.
• Regardless, given the well-‐known morbidity associated with this prac.ce, interven.ons to ensure appropriate access to transgender care are urgently needed.
AKNOWLEDGEMENTS
heps://benjaminochoa.files.wordpress.com/2013/02/hombre-‐inyectandose1.jpg
RESULTS
We would like to thank all the par.cipants, A.T.T.TA. interviewers for their assistance in data collec.on, and the rest of the research team involved in this study. Supported by a grant from the Open Society Founda.ons (#OR2012-‐01282).
• In total, 450 transgender women were included: • Median age: 30 years old (IQR 25-‐37) • History of sex work involvement: 376 (83.6%) • Self-‐reported HIV infec.on: 104 (23.1%) • Self-‐reported HCV infec.on: 18 (4%)
• 277 (61.6%) reported having ever injected industrial silicone for body modifica.on purposes. • 91.7% of them were injected by a transgender peer
• Unadjusted and adjusted correlates of silicone injec.on are shown in Table 1.
!"#$#%&'$()&(%*+,,)*-#&(.*/+-0*
12#,34)&',*+-**/567*!80*
9,34)&',*+-**/567*!80*
82,(:(,4#;<;':';*=#%&.$)* ! !
"#$!%&$'!($)'!*+,$'-!.! /012!%/013!4!/015-! >?@6*/>?@A*B*>?@C0*6$+78!'$&*'9$,!:;<!=9)9>=!%&*=?9?@$!@=0!A$#)9?@$B!>ACA*DA-!.!
/0EF!%/015!4!G0EH-! /0/H!%10E1!4!G01F-!
I,>J)9?*A)+!+$@$+!%KL?#L!=JL**+!@=0!ML?#L!=JL**+-!.! 10E/!%10F5!4!/01E-! 10EN!%10FH!4!/0/H-!6$+78!'$&*'9$,!:O<!=9)9>=!%&*=?9?@$!@=0!A$#)9?@$B!>ACA*DA-!
/0NN!%1025!4!F0E3-! 4!
IP9$A,$,!L$)+9L!?A=>')AJ$! /01/!%10N/!4!/0NN-! 4!
D.%(#;<)&$4%&4$#;*=#%&.$)* ! !
Q*'$?#A8R*'A!=9)9>=!%($=!@=0!A*-!.! 30/5!%/0FF!4!E011-! E?AA*/>?EC*B*F?6A0*
69)R+$!L*>=?A#!%($=!@=0!A*-! 10H5!%10NG!4!/02N-! 4!
:?=9*'(!*7!=$P!D*'C!?A@*+@$S$A9!%($=!@=0!A*-!.! 20/N!%G0HF!4!H01E-! E?A@*/>?GF*B*G?>A0*
T?=J'?S?A)9?*A!R(!L$)+9LJ)'$!D*'C$'=!%($=!@=0!A*-!.! /02E!%/012!4!G03F-! /01G!%10N3!4!/0NF-!I@$'!)@*?,$,!L$)+9L!=$'@?J$=!,>$!9*!9')A=#$A,$'!?,$A9?9(!%($=!@=0!A*-!.!
/0EE!%/0/H!4!G0N3-! >?G>*/>?@>*B*A?6G0*
I@$'!)''$=9$,!%($=!@=0!A*-!.! 3055!%G0F/!4!N0GN-! A?@@*/>?@G*B*E?C@0*I@$'!$P&$'?$AJ$,!&*+?J$!@?*+$AJ$!%($=!@=0!A*-!.! G02F!%/0EG!4!30EN-! 10H2!%102N!4!/0N/-!
.!6?#A?7?J)A9!)9!&!M!10/1!)A,!$A9$'$,!?A9*!9L$!S>+9?@)'?)R+$!S*,$+!!
Table 1. Factors associated with industrial silicone injec1on among transgender women in Argen1na (n=450)